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Background: Acute spinal cord injury (SCI) leads to a series of reactive changes and causes severe neurological
deficits. A pronounced inflammation contributes to secondary pathology after SCI. Astroglia respond to SCI by
proliferating, migrating, and altering phenotype. The impact of reactive gliosis on the pathogenesis of SCI is not
fully understood. Our previous study has identified an inflammatory modulating protein, proliferation related acidic
leucine-rich protein (PAL31) which is upregulated in the microglia/macrophage of injured cords. Because PAL31
participates in cell cycle progression and reactive astroglia often appears in the injured cord, we aim to examine
whether PAL31 is involved in glial modulation after injury.
Results: Enhanced PAL31 expression was shown not only in microglia/macrophages but also in spinal astroglia
after SCI. Cell culture study reveal that overexpression of PAL31 in mixed glial cells or in C6 astroglia significantly
reduced LPS/IFNγ stimulation. Further, enhanced PAL31 expression in C6 astroglia protected cells from H2O2
toxicity; however, this did not affect its proliferative activity. The inhibiting effect of PAL31 on LPS/IFNγ stimulation
was observed in glia or C6 after co-culture with neuronal cells. The results demonstrated that the overexpressed
PAL31 in glial cells protected neuronal damages through inhibiting NF-kB signaling and iNOS.
Conclusions: Our data suggest that PAL31upregulation might be beneficial after spinal cord injury. Reactive gliosis
might become a good target for future therapeutic interventions.
Keywords: Spinal cord injury, Proliferation related acidic leucine-rich protein, Inflammation, H2O2 toxicity, Astroglia,
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Spinal cord injury (SCI) causes severe and often permanent
neurological deficits through direct trauma and delayed
secondary damage [1,2]. The cascade of secondary injury is
mediated by inflammatory response, involving macrophage
and microglial activation [3-5]. Neurons in injured cord
have become more sensitive to a secondary injury. Several
lines of evidence have reported that attenuating inflamma-
tion decreases secondary damage and the functional deficit
after SCI [6,7]. Astrocytes respond to SCI by proliferating,
migrating, and altering phenotype. Reactive astrocytes can
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unless otherwise stated.physical barrier between the lesion and the surrounding
tissue [8,9]. These cells are considered to be detrimental for
axonal regeneration, but their function remains elusive.
After SCI, intracellular Ca2+ is transiently increased and
initiates several damaging effects. One of these effects is
activation of nitric oxide synthase (NOS) in mitochondria
and cytoplasm. The activated NOS can generate peroxyni-
trite anion (ONOO−), a reactive product of superoxide
radical with nitric oxide. Peroxynitrite can trigger cellular
damage by a variety of mechanisms [10,11]. Glial cells
(astrocytes and microglia) synthesize NO after the tran-
scriptional expression of inducible NOS which can be
promoted by the endotoxin lipopolysaccharide (LPS) and/
or by certain cytokines, such as interferon-γ (IFNγ) [12,13].
Cyclic AMP has been shown to play critical role in
neural regeneration [14] and this effect is mediated through
the activation of protein kinase A (PKA). Previously, we
had identified a phospho-motif in PKA substrates that
correlated with SCI rat neural regeneration [15]. Thistd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Tseng et al. Journal of Biomedical Science 2014, 21:60 Page 2 of 12
http://www.jbiomedsci.com/content/21/1/60novel molecule was identified as a proliferation related
acidic leucine-rich protein (PAL31) with molecular weight
of 31 kDa. PAL31 had been discovered in the develop-
ing nervous system and its expression level decreased
following maturation. The functions of PAL31 has been
discovered that participated in cell cycle progression [16],
caspase-3 inhibition [17], and inflammatory modulation
[15]. Interestingly, PAL31 was found to express in the
infiltrated macrophages in the epicenter of the injured
spinal cord and the amount of PAL31 reached its peak
level over 6 days after transection of spinal cord [15].
This suggests that PAL31 may play a modulatory role
on inflammation during SCI. On the other hand, PAL31
had been reported to co-localize with PCNA which partic-
ipated in DNA replication and repair [16]. Proliferation
of astroglia and microglia is increased at 1–7 days after
SCI [18]. Astrocytes in spared gray and white matter of
spinal cord undergo hypertrophy or gliosis after injury.
Because PAL31 participates in cell cycle progression
and reactive astroglia often appears in the injured cord,
PAL31 could be expressed in spinal glia after SCI. In
the present study, we aim to examine whether PAL31 is
involved in glial modulation after spinal cord injury. To
reveal the molecular mechanism of PAL31 in astroglia,
a full-length PAL31 cDNA was first prepared. We con-
ducted PAL31 overexpressing experiments in primary
cultures derived from spinal cord tissues to mimic the
interaction of glia and neurons in vivo. Here we present
evidence showing that enhanced expression of PAL31
in astroglia might be beneficial after spinal cord injury.
Methods
Materials
Lipopolysaccharide (LPS; Escherichia coli O111:B4) and
antibiotics were purchased from Sigma-Aldrich (St. Louis,
USA). Rat interferon-γ (IFNγ) was from Peprotech. A
methylthiazol tetrazolium (MTT) kit was from Chemicon
(USA). Culture multi-wells and pipettes were obtained
from Orange Scientific (Graignette, Belgium). Cultured
media and fetal bovine serum (FBS) were purchased
from Gibco (Invitrogen Corporation, USA). Other
reagents were purchased from Sigma-Aldrich unless
stated otherwise.
Spinal cord injury
Adult female Spraque-Dawley (SD) rats (250 ± 20 g)
were used for inducing spinal cord injury (SCI) and the
operation procedures have been described elsewhere
[19-22]. Briefly, adult female SD rats were anesthetized
with isoflurane and a laminectomy was performed. Verte-
brate thoracic T7–T10 was exposed. Rats underwent a
complete ‘transection’ operation at thoracic T8. Following
injury, the incision was closed and sutured. Each rat was
then returned to its cage. To avoid urinary tract infections,manual emptying of the urinary bladder was carried out
twice daily. All surgical interventions and animal care
were performed in accordance with the Laboratory
Animal Welfare Act, the Guide for the Care and Use of
Laboratory Animals, National Institutes of Health and were
approved by the Animal Committee of Taipei Veterans
General Hospital, Taiwan.
Cell culture
Mixed neuronal/glial cultures were prepared from em-
bryonic SD rat spinal cords at gestation days 14–16 as
described previously [23-25]. Briefly, cells were dissociated
with mixtures of papain/protease/deoxyribonuclease I
(0.1:0.1: 0.03%) and plated in poly-lysine coated multi-
well plates (12 × 24 mm) or on mixed glial cultures (for
co-culture study, see below). Mixed glial cultures were
prepared from adult SD rat spinal cords following methods
described previously [26,27] with modifications. Briefly,
spinal cords, free of meninges, were dissociated by tryp-
sinization. The dissociated cells were passed through nylon
cloths (70 um), plated in 75 cm2 flasks and maintained
in DMEM supplemented with 10% FBS. The cells were
incubated at 37°C in a water-saturated atmosphere of
5% CO2/95% air. Confluent cultures were purified on
the 10th day by shaking 5 hrs at 180 rpm to remove the
suspended cells. Cultures in the flasks were replated into
multiwell plates. Subconfluent mixed glial cell cultures
were used for PAL31 or GFP overexpression experiment
(see below). C6 glioma were obtained from ATCC
(Manassas, VA, USA Catalog No. 30–2004). The base
medium for this cell line is ATCC-formulated F-12 K
Medium. C6 cultures were maintained in ATCC-formu-
lated F-12 K Medium supplemented with 2.5% FBS and
12.5% horse serum during cell expansion. C6 glioma were
adapted to DMEM+ 10% FBS one passage before cDNA
transfection experiments and thereafter [28].
Construction of PAL31 vector and transfection of vector
to cultures
Vectors used in these studies were constructed by inserting
the human PAL31 cDNA into the pEGFP-C1 vector
(BD Biosciences Clontech, San Jose, CA, USA). Briefly,
full-length human PAL31cDNA was amplified from
Marathon-Ready cDNA (Clontech, CA, USA) by PCR.
Primers for PAL31 were PAL31-forward 5’-GAA,TTC,
AAT,GGA,CAT,GAA,GAG, GAG-3’and PAL31-reverse
5’-GAA, GGA,GAA,GAT,GAC,TAA,TCT,AGA-3’. Full
length PAL31 cDNA was then ligated into the EcoRI
and XbaI site of pEGFP-C1 vector yielding the plasmid
EP, and verified by DNA sequencing. For cell culture
transfection, 5 μg each of the recombinant plasmid EP
(pPAL31) or EV (pEGFP-C1) were first mixed with T-
Profect transfection reagent (JF Ji-Feng Biotechnology,
Taiwan) in cultured medium containing 5% FBS. The
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for 16 hr. The cells were then replaced with growth
medium. The resulted transfected cells were used in
the present study.
Construction of the pal31 siRNA
We designed oligonucleotides as pal31 gene hairpin siRNA
to knockdown endogenous PAL31 expression in cultures.
Two sequences of siRNA were custom-ordered synthesis
from Ambion Life Technologies as shown in Additional
file 1 supporting information. siRNA was transfected to
C6 cultures using a Lipofectamine RNAiMax reagent
(Invitrogen) by a protocol suggested by the provider
(166 pmol siRNA for cells in 6 cm dish). Two ~ three
days after confirming the knockdown of PAL31 in C6
cells, the cultures were exposed to H2O2 challenge.
H2O2 or LPS/IFNγ exposure
GFP or PAL31-overexpressing cells were maintained in
10% FCS containing medium. Doses of hydrogen peroxide
(0.5-1 mM) were added to the culture medium for 4 hr.
The survived cells were analyzed for the degree of MTT
reduction. In the experiments of LPS/IFNγ exposure,
transduced cells were maintained in serum-containing
medium (DMEM +10% FBS). During LPS /IFNγ treatment,
the culture medium was switched to DMEM +4% FBS. LPS
(4 μg/mL) and IFNγ (10 ng/mL) were added to cultures
and incubated for 2 hrs ~ 2 days. The medium was then
saved for nitrite assay, while cells were fixed for immuno-
staining or harvested for western blot analysis.
Fluorescent immunohistochemistry of spinal cord tissue
Tissue slides were washed twice with PBS, permeabilized
with 0.5% Triton X-100 in PBS for 5 min, and incubated
in 0.05% Tween 20 in PBS for 5 min at room temperature.
Fixed tissue were pre-incubated for 30 min in PBS
containing 2% BSA and then incubated for 1 h at 37°C
with goat anti-PAL31 (Novus, NB100-1199), ED-1 (Serotec,
MCA341) and GFAP (Chemicon, AB5040) (dilution
1:500~1:1000). After three washes with PBS, they were
incubated for 30 min with FITC-conjugated anti-goat antibody
(dilution 1:100; Zymed, CA) and Alexa fluro 568 (Molecular
probes, A11004). The tissues were incubated in 50 mg/ml of
DAPI in PBS for nuclei staining, and were washed twice with
PBS before mounting with artifading reagent. Images of sam-
ples were obtained with a fluorescent microscope equipped
with fluorescence optics and a CCD camera. Micrography was
performed using a 10X and 20X objective and images were
processed with imaging software (MetaMorph Imaging
System, Universal Imaging Corp, Downingtown, PA, US).
Cell survival MTT assay
Degree of MTT reduction, which is reduced to a blue
formazan product by viable cells, followed a methoddescribed in Tsai et al. [26]. Following treatment, aliquots
of MTT stock solution (5 mg/ml) was added to each well
and incubated at 37°C for 3 hr. At the end of incubation,
the media were aspirated and cells were solubilized in acid
isopropanol (0.04-0.1 N HCl in isopropanol). The resulted
solution was measured spectrophotometrically at 590 nm
with background subtraction at 630–690 nm.
The nitrite assay
The production of nitric oxide (NO) was assayed as the
accumulation of nitrite in the medium using colorimetric
reaction with Griess reagents (1% sulfanilaminde/0.1%
naphthylethylene diamine dihydrochloride/2% phosphoric
acid) as described by Tsai et al. [23] and Tseng et al. [29].
After LPS/IFNγ treatment, the culture medium was
collected, mixed with Griess reagents and incubated at
room temperature for 10 min. The absorbance of the
resultant products was measured at 540 nm. Sodium
nitrite (NaNO2) was used as the standard to calculate
nitrogen dioxide (NO2) concentrations.
Western blot analysis
At designated time, cells were homogenized in lysis buffer
containing 10 mM Tris, pH 7.4, 50 mM NaCl, 1% NP-40,
1× protease inhibitor (Roche, Indianapolis, IN, USA),
30 mM Na4P2O7, 1 mM Na3VO4, and 30 mM NaF.
Protein concentration was assayed using a Bio-Rad DC
kit (Hercules, CA, USA). The protein extract (20 μg/
lane) was next separated on 12.5% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
and then transferred to a polyvinylidene difluoride filter
(Millipore, Bedford, MA, USA) as described [30]. Primary
antibodies such as Anp32b (PAL31) (Novus, NB100-
1199), PCNA (Santa cruz, SC-9857), GFP (Santa cruz,
SC-5385), iNOS (Abcam, 47350), pNF-kB (Cell signaling,
#3033), NF-kB (Cell signaling, #8242) and actin (Santa
cruz, SC-1616), were used at 1000–2000 fold dilution.
Horseradish peroxidase-conjugated antibody was used as
the secondary antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA). The protein bands were visualized by
enhanced chemiluminescence development (PerkinElmer
Life Sciences, Waltham, MA, USA). The detailed proce-
dures for the western blotting were the same as described
in the New England Nuclear western blot manual, which
is provided by the manufacturer.
Statistical analysis
All measurements were performed blind to each group.
Experimental data were expressed as the mean of inde-
pendent values ± s.e. and were analyzed using one-way
analysis of variance (ANOVA) followed by Bonferroni
post hoc test. Data in Figure 1D and Figure 2B was





Figure 1 Upregulated PAL31 expression was observed not only in microglia/ macrophage but also in glial cells near the injury site.
(A) Normal thoracic spinal cord section showing few ED-1 positive cells (red). (B) Normal thoracic spinal cord section showing GFAP positive
cells (red). (C) Representative micrograph showing colocalization of upregulated PAL31 (green) with microglia/macrophage (ED1 positive cells)
(D) Representative micrograph showing colocalization of upregulated PAL31 with astroglia (GFAP positive cells). (E) High power image showing
the colocalization of upregulated PAL31 with ED1 positive macrophage/microglia (arrowhead) (F) High power image demonstrating the colocalization
of upregulated PAL31 with GFAP positive astroglia (arrow). Magnification: 200X (A-D) and 1000X (E&F).
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tically significant.
Results
Upregulated PAL31 expression was observed not only in
microglia/macrophage but also in glia cells near the
injury site
In our previous study, PAL31 was found to express in the
infiltrated macrophages in the epicenter of the injured
spinal cord [15]. The amount of PAL31 reached its peak
level over 6 days after transection of spinal cord. The
present work employed same injury model, collected thor-
acic spinal cords at one week post-injury and examined
whether PAL31 expression was present in other cell types
of this injured spinal cord.
As expected, PAL31 upregulation was observed in
ED-1-immunoreactive microglia/macrophage (Figure 1Cand E; Arrowheads), compared to that in normal cord
(Figure 1A). Interestingly, near the transected stump,
GFAP-positive astroglia were found to express PAL31
(Figure 1D and F). As shown in Figure 1F (Arrow),
PAL31 immunoreactivity (green) co-localized with GFAP-
positive cells (red). This phenomenon indicated that
PAL31 might have important roles in glia cell after
spinal cord injury.
Anti-inflammatory effect of overexpressing PAL31 in
primary mixed glia culture
To evaluate the effects of upregulated PAL31 in glial cells,
we constructed full-length PAL31 cDNA and conducted
PAL31 overexpressing experiments in primary cultures
derived from spinal cord tissues to mimic the interaction
of glia and neurons in vivo. To identify cell types in mixed
glial cultures prepared from adult spinal cords, we used
Figure 2 Overexpression of PAL31 in mixed glial culture effectively reduced LPS/IFNγ stimulation after co-culture with spinal cord
neuron-glial cultures. (A) ED-1- immunoreactive microglia/macrophage in confluent mixed glial cultures (B) S100- immunoreactive astroglia in
confluent mixed glial cultures (C) LPS/IFNγ-stimulated neuron-glial co-cultures (Glia/GFP + neuron) showing expression of both iNOS and GFP
(D) LPS/IFNγ-stimulated neuron-glial co-cultures (Glia/PAL31+ neuron) showing expression of both iNOS and PAL31. (E) Quantitative analysis of
released nitric oxide, as a form of nitrite, in LPS/IFNγ-stimulated or non-stimulated neuron-glial co-culture. Mixed glial cultures were transfected with
pGFP or pPAL31 before seeding spinal cord neurons. Co-cultures were then treated with LPS/IFNγ for 2 days. Medium were saved for nitrite level
determination, while cells were processed for immunostaining with iNOS. *P < 0.05, n = 4. PAL31 overexpressing co-cultures (+LPS/IFNγ)
compared to GFP overexpressing co-cultures (+LPS/IFNγ). Magnification 200X (A-D).
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for immunocytochemistry. As shown in Figure 2A and
B, mixed glial cultures comprised predominant astroglia
(S100-immunoreactive cells) and few activated ED-1-
immunoreactive microglia. Human full-length PAL31
cDNA was successfully made and further inserted into
pEGFP-C1 yielding a plasmid with GFP-tagged PAL31.
The resulted plasmid each, pEGFP or pPAL31, wasadded to mixed glial cultures with transfection reagent
(T-Profect). As a result, more than 50% of cells expressed
GFP. GFP expression was found in the cytosol of Glia/
GFP-cultures (Figure 2C, green) and in the nucleus of
PAL31/GFP-cultures (Figure 2D, green), indicating correct
subcellular localization of GFP-tagged PAL31. Spinal
cord neuronal cultures were then seeded to GFP- or
PAL31-transfected mixed glial cultures (Glia/GFP or
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overexpression conferred protection against stimulation
by LPS and interferon-γ (IFNγ). LPS, an endotoxin, is a
powerful immune challenge associated with an increase of
numerous cytokines and inducible nitric oxide synthase
(iNOS) expression. Figure 2C and D shows that numbers
of LPS/IFNγ-stimulated iNOS positive cells were less in
Glia/PAL31-cocultures than in Glia/GFP-cocultures. The
co-cultured media were subjected to nitrite assay to
evaluate nitric oxide production. Figure 2E showed the
released nitrite was 53.49 ± 6.15 μM in Glia/GFP + Neu-
rons cocultures stimulated by LPS/IFNγ. The Glia/
PAL31 + Neurons + LPS/IFNγ released significantly less
nitrite (34.94 ± 7.61 μM; p < 0.05). Thus, overexpressed
PAL31 in glia not only attenuated LPS/IFNγ-stimulated
iNOS expression but also reduced the accompanied
NO production. To further examine the functions of
PAL31 in glial cells, we used homogenous C6 astro-
glioma cell line to substitute the primary mixed glia.Overexpressing PAL31 in C6 cell did not affect the cell
proliferation
C6 cells were transfected with pEGFP or pGFP-PAL31
using T-profect. The transfection efficiency reached >50%
(GFP/phase-contrast superimposed micrograph; Figure 3A
and B). GFP-tagged PAL31 was found to express in
the nucleus of C6 (Figure 3B), whereas GFP expression
was predominant in the cytosol of GFP-C6 (Figure 3A).
Western blot analysis of these cultures further confirmed
the corrected size of overexpressed PAL31 in C6/PAL31
(~58 kDa for GFP-tagged PAL31; Figure 3C).The anti-
body ANP32b could detect endogenous PAL31 protein
(~31 kDa) and the GFP antibody detected the tag of
the transfected PAL31 and GFP protein. The results of
western blot showed that the overexpressed PAL31
cell lysate could be detected by PAL31 and GFP anti-
bodies at ~58 kDa and by anti-GFP at ~27 kDa. This
indicated correct size of GFP tagged PAL31 with some
breakdown signal (~27 kDa). This did not affect the
results of our experiment. Endogenous PAL31 was detected
by ANP32b at 31 kDa with equivalent level in both C6/
GFP and C6/PAL31 cells (Figure 3C). Levels of actin
were used as a loading control. PAL31 had been reported
to co-localize with PCNA which participated in DNA
replication and repair [16]. Therefore, we examined
whether PAL31 overexpressing in C6 affected PCNA
expression and the cell’s proliferative activity (by MTT
assay). As a result, enhanced PAL31 expression in cells
did not affect the expression level of PCNA (Figure 3C) as
well as the MTT assay results (Figure 3D). The prolifer-
ative activity (degree of MTT reduction) in C6 at all
time intervals (0 ~ 72 hr) were not significantly different
between C6/GFP and C6/PAL31 groups (Figure 3D).Enhanced PAL31 expression in C6 protected cells from
H2O2 toxicity
To evaluate the cytoprotective effect of PAL31, H2O2
(0.5 ~ 1 mM) was added to GFP- or PAL31-transfected
C6 for four hours. The survived cells were then analyzed
by MTT assay. After H2O2 treatment, some cells were
damaged and detached from the culture plates, only
survived cells were able to reduce MTT into a blue
formazan product. Figure 4A and B showed that H2O2
induced dose-dependent cell death in C6/GFP. Compared
to H2O2-treated C6/GFP, C6/PAL31 were significantly
more resistant to H2O2 -toxicity (P < 0.05 at 0.5 mM or
1 mM H2O2; Figure 4B). The survival ratio of C6/GFP by
0.5 mM H2O2 treatment was 78.52 ± 7.45% and that by
1 mM H2O2 treatment was 41.18 ± 6.13%. In C6/PAL31
group, the survival ratio by 0.5 mM H2O2 treatment was
101.32 ± 8.4% and that by 1 mM H2O2 treatment was
64.95 ± 10.45%.
To further confirm the function of PAL31, we employed
pal31 siRNA to C6 culture. As shown in Figure 4C, the
expression level of PAL31 protein was substantially
reduced by pal31 siRNA at dose≧166 picomole/6 cm
dish, compared with the negative control siRNA. To
examine the knockdown cells’ response to toxin challenge,
we subsequently treated cells with 1 mMH2O2 for 4 hours.
Results demonstrated that pal31 siRNA treatment aggra-
vated H2O2 toxicity to cells. These results consistently
suggested that PAL31 might exert a cytoprotective effect
on glial cells.Overexpression of PAL31 in C6 attenuated
LPS/IFNγ-stimulated NO production
The transfected C6 (C6/GFP or C6/PAL31) were stimu-
lated by LPS and IFNγ, the culture medium were collected
at 2 days later to evaluate NO production. As shown in
Figure 5A, overexpressing PAL31 in C6 cells after LPS/
IFNγ treatment produced 31.93 ± 0.08 μM nitrite which
was significantly less nitrite level than C6/GFP-LPS/IFN γ
treated group (37.13 ± 0.34 μM nitrite; P < 0.05). To inves-
tigate whether PAL31 overexpression suppressed NF-kB
signaling on LPS/IFNγ stimulation, we treated C6/GFP
and C6/PAL31 with LPS/IFNγ for shorter period (2 hr)
and harvested cells for western blot analysis. As a result,
Figure 5C shows a reduced level of phosphorylated NF-kB
in LPS/IFNγ –treated C6/PAL31, compared to that in
C6/GFP.
To confirm the overexpressed PAL31 in C6 glial cells
may protect neurons from cell death by NO, we used
the co-cultures assay (spinal cord neurons seeded to C6/
GFP or C6/PAL31) and collected the conditioned medium
to evaluate NO production. And cells were harvested for
western blot or morphological analysis. Figure 5B showed
that C6/GFP + Neurons (+LPS/IFNγ) group released
Figure 3 Overexpression of PAL31 in C6 did not affect the cell proliferative activity. (A) GFP/bright field-superimposed micrograph in GFP
overexpressing cells showing > 50% transfective efficiency (B) GFP-PAL31/bright field-micrograph in PAL31 overexpressing C6 showing correct
nuclear localization of GFP-tagged PAL31 and transfection effeciency. (C) Western blot analysis showing the expression of GFP (~27 kDa), GFP-tagged
PAL31 (~58 kDa), PCNA (~34 kDa), endogenous PAL31 (~31 kDa) and Actin (~43 kDa) in GFP- or PAL31-C6 cultures. The level of PCNA, a protein
expressing in nuclear during DNA synthesis, in cells did not alter after overexpression of GFP or GFP-tagged PAL31. Actin works as a loading
control. (D) MTT assay in the transfected cells at 4 different time intervals (from Ctrl to 72 hours). Ctrl represents the cells after subculture and
overnight incubation. The data in each time points were analyzed by two-way ANOVA and Bonferroni post hoc test. No significance, compared GFP
and GFP tagged PAL31 groups. n = 3. Magnification 100X (A-B).
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PAL31 + Neurons group (+LPS/IFNγ) generated signifi-
cantly less nitrite (6.63 ± 3.45 μM; P < 0.05) to the medium.
Figure 5D demonstrates a reduced iNOS expression in
PAL31-overexpressed cocultures than in GFP-cocultures
after LPS/IFNγ treatment. The numbers of pNF-kB-positive
cells in LPS/IFNγ-treated PAL31 cocultures (Figure 5F) wassignificantly less than that in LPS/IFNγ-treated GFP cocul-
tures (Figure 5E). Figure 5G confirms that this response is
related to NF-kB-mediated signaling. Combining these data
in Figures 2, 3, 4 and 5, our in vitro model could mimic
the in vivo model to prove that PAL31 in glia may have
the important functions of immunomodulation after
spinal cord injury.
Figure 4 Effect of overexpression or knockdown of PAL31 in C6 on H2O2-induced toxicity. (A) Representative micrographs showing C6
overexpressing GFP or GFP-tagged PAL31 after being treated with H2O2 (0 ~ 1 mM) for 4 hours. (B) MTT assay in GFP- or GFP-PAL31-overexpressed
C6 after H2O2 treatment showing significant difference (cytoprotective effect of PAL31) at 0.5 mM and 1 mM H2O2 treatment between C6/GFP and
C6/PAL31 groups. The data in each dosage were analyzed by two-way ANOVA and Bonferroni post hoc test. *P < 0.05, GFP (+H2O2) compared to
PAL31 (+H2O2), n = 4, at 0.5 mM and 1 mM. (C) Western blot analysis of pal31 siRNA-treated C6 showing knockdown of PAL31 expression by PAL31
silencer using 41.5 (lane1), 83 (lane2), and 166 (lane 3) picomole of pal31 siRNA or 332 picomole negative control. Actin works as a loading control.
(D) MTT assay in Negative- or PAL31 silencer transfected C6 after H2O2 treatment showing significant difference at 1 mM H2O2 treatment between
C6/Negative and C6/PAL31 siRNA groups. *P < 0.05, Negative (+H2O2) compared to PAL31 siRNA (+H2O2), n = 4. Magnification 100X (A).
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Figure 5 Overexpression of PAL31 in C6 effectively attenuated LPS/IFNγ stimulation in C6 or in C6 after co-culture with spinal neuron-glial
cultures. (A) Level of nitrite release in C6 overexpressing GFP (C6/GFP) or GFP-tagged PAL31 (C6/PAL31) at 2 days after LPS/IFNγ stimulation (B) Levels
of nitrite release in the transfected C6 co-cultured with spinal neuron-glial culture after LPS/IFNγ stimulation for 2 days. (C) Western blot analysis in C6/
GFP or C6/PAL31 showing the expression of phosphorylated NF-kB is downregulated by PAL31 after LPS/IFNγ stimulation. NF-kB and GAPDH work as
control. (D) Western blot analysis showing iNOS expression in the tranfected C6 co-cultured with spinal neuron-glial cultures after LPS/IFNγ stimulation.
GAPDH works as a control. (E) Phosphorylated NF-kB-positive cells in LPS/IFNγ-stimulated neuron-C6 co-cultures (C6/GFP + neuron). (F) Phosphorylated
NF-kB-positive cells in LPS/IFNγ-stimulated neuron-C6 co-cultures (C6/PAL31+ neuron). (G) Quantitative analysis of phosphorylated NF-kB positive cells
in LPS/IFNγ-stimulated neuron-C6 co-culture shown in (E&F). C6 glial cultures were transfected with pGFP or pPAL31 before seeding spinal cord
neurons. *P < 0.05, C6/GFP (+LPS/IFNγ) compared to C6/PAL31(+LPS/IFNγ), n = 3 ~ 4.
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The central observation of the present study is that
PAL31 overexpression was found to localize in glia in
addition to infiltrated macrophage/microglia in the
injured spinal cord. This work examines the role of
enhanced PAL31expression in spinal cord cultures,
emphasizing on glial cells. Results showed that PAL31
overexpression in mixed glial cultures or in C6 astroglia
was beneficial. This conclusion is supported by the
following evidence. First, anti-inflammatory effect of
overexpressing PAL31 was shown in primary mixed
glia culture. Second, enhanced expression of PAL31 in
C6 astroglia protected cells from H2O2 toxicity. By
contrast, knockdown expression of PAL31 rendered C6
more susceptible to H2O2 toxicity. However, this did not
affect the proliferative activity. Third, overexpression of
PAL31 in C6 astroglia attenuated LPS/IFNγ-stimulated
NO production. Lastly, inhibiting LPS/IFNγ stimulation
by PAL31 was observed in glia or C6 after co-culture with
neuronal cells. The primary co-culture study demonstrated
our in vitro assay mimicking the in vivo model to evaluate
the neuron-glial interaction during inflammation.
After LPS/IFNγ stimulation, nuclear factor κB (NF-κB)
is phosphorylated, translocated into nucleus and activate
transcription of downstream genes including iNOS [34,35].
In the present study, levels of NF-kB phosphorylation and
nitrite were concurrently reduced by PAL31 overexpression
in C6 and co-cultures after LPS/IFNγ stimulation. This
might suggest that PAL31 suppress NF-kB signaling and
thus reduce iNOS expression on LPS/IFNγ treatment.
The functions of glia after spinal cord injury include
scar formation to prevent further neural damages [36] and
protect neurons [37]. To further examine the functions
of PAL31 in glial cells, we employed homogenous cell
population-C6 astroglia which was generated from rat
glioma and expressed S100 protein [38]. Furthermore,
the transfection efficiency of GFP-tagged PAL31 in C6
was higher than in primary mixed glial culture. As shown
in Figure 3B, the overexpressed PAL31 was specifically
localized in the nucleus due to its nuclear localization
signal in its protein sequence, consistent with previous
studies [39,40]. Western blot analysis of these transfected
C6 further confirms overexpression of GFP-tagged PAL31
with correct protein size and immunoreactivity (Figure 3C).
PAL31 had been reported to co-localize with PCNA
which participated in DNA replication and repair [16].
The cell cycle progression in S phase needs PAL31 [40].
However, the present results could not obtain similar
effect. Overexpression of PLA31 did not alter PCNA level
neither the proliferative activity in C6 cells (Figure 3C
and D). Interestingly, PAL31 overexpressing in C6 could
significantly reduce H2O2-induced cell death (Figure 4).
This effect might be due to overexpressed PAL31
working as a caspase-3 substrate [17], rendering thePAL31-transfected cells more resistant to H2O2 toxicity.
By contrast, PAL31 knockdown cells were more suscep-
tible to H2O2 challenge. The results of over-expression
and the small interfering RNA (siRNA) knockdown of
PAL31 in C6 cells further suggested that the function of
PAL31 might be negatively regulated.
Astrocytes become “reactive” in response to spinal cord
injury. Nevertheless, the harmful and beneficial functions
of reactive astrocytes are not well understood. The roles
of astroglia in neural regeneration after spinal cord injury
were still unclear. Immunomodulation of astroglia might
play an important role. Previous studies demonstrated that
iNOS upregulation in glia cells caused neurodegeneration
in Parkinson’s disease [41] and the activated immune cell
in brain were correlated with Alzheimer disease [42].
These studies gave us a hit to overcome the unfavorable
microenvironment for regeneration after spinal cord
injury. Modulation of astroglial reactivity should be paid
more attention. In our previous studies of spinal cord
regeneration, PAL31 was suggested to play a key role in
spinal cord regeneration after injury [2]. The present find-
ings are in keeping with our previous observations that
both microglia and GFAP positive astroglia enhanced
PAL31 expression near the lesion site after transected
spinal cord injury (Figure 1). This phenomenon might
be related to the important endogenous regenerative
mechanisms. Reactive astrocytes exert both pro- and
anti-inflammatory functions at different locations and at
different times in response to injury and during repair.
There were many studies focused on astroglia as a thera-
peutic target [43]. PAL31 effectively reduced LPS/IFNγ
stimulation and also protected cells from H2O2 toxicity in
astroglia in the present study. PAL31 may provide new
means to study the activities and regulation of reactive
astrocytes after CNS insults in vivo.
Conclusions
In conclusion, the present study provides evidence that
overexpressed PAL31 in glia cells could reduce LPS/
IFNγ stimulation and H2O2 toxicity. Together with our
previous study of immunomodulatory role of PAL31 in
macrophages after SCI, this study suggests a beneficial
role of PAL31 in glial cells after injury. A better understand-
ing of glial cell roles during the complex multicellular
interactions after CNS insults is important in developing
potential therapeutic interventions.
Additional file
Additional file 1: PAL31 knockdown clones showing the sequence
of siRNA of PAL31.
Competing interests
The authors declare that they have no competing interests.
Tseng et al. Journal of Biomedical Science 2014, 21:60 Page 11 of 12
http://www.jbiomedsci.com/content/21/1/60Authors’ contributions
FWT and DYL carried out cell culture and IHC studies. FWT and MJT
participated in the design of the study and drafted the manuscript. MJT,
WCH and HC conceived of the study, participated in its design and coordination,
and collectively prepared the manuscript. All authors read and approved the
final manuscript.
Acknowledgments
This work was supported financially by research grants (V102E6-001, V101E6-
001, V100S6-001, and V99S6-001) from the Taipei Veterans General Hospital in
Taiwan, by grants (NSC 98-2314-B-075-007-MY2, NSC 99-2628-B-010-009-MY3,
NSC 101-2314-B-010-006-MY3, NSC102-2314-B-075-052) from the National
Science Council in Taiwan, and by a grant from the Ministry of Education
(Aim for the Top University Plan).The authors thank Ms. Ching-Jung Chen and
Mr. Boruei Chen for their excellent assistance. We thank Ms. Hsin-Yi Huang from
the Biostatistics Task Force of Taipei Veterans General Hospital for her statistical
assistance.
Author details
1Department and Institute of Pharmacology, School of Medicine, National
Yang-Ming University, Taipei, Taiwan. 2Neural Regeneration Laboratory,
Neurological Institute, Taipei Veterans General Hospital, No 322, Shih-Pai
Road, Sec. 2, Taipei 112, Taiwan. 3Center for Neural Regeneration,
Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
4Faculty of Medicine, School of Medicine, National Yang-Ming University,
Taipei, Taiwan.
Received: 13 March 2014 Accepted: 1 June 2014
Published: 17 July 2014
References
1. Tator CH: Experimental and clinical studies of the pathophysiology
and management of acute spinal cord injury. J Spinal Cord Med 1996,
19(4):206–214.
2. Dumont RJ, Okonkwo DO, Verma S, Hurlbert RJ, Boulos PT, Ellegala DB,
Dumont AS: Acute spinal cord injury, part I: pathophysiologic
mechanisms. Clin Neuropharmacol 2001, 24(5):254–264.
3. Dusart I, Schwab ME: Secondary cell death and the inflammatory reaction
after dorsal hemisection of the rat spinal cord. Eur J Neurosci 1994,
6(5):712–724.
4. Popovich PG, Guan Z, McGaughy V, Fisher L, Hickey WF, Basso DM: The
neuropathological and behavioral consequences of intraspinal microglial/
macrophage activation. J Neuropathol Exp Neurol 2002, 61(7):623–633.
5. Keane RW, Davis AR, Dietrich WD: Inflammatory and apoptotic signaling
after spinal cord injury. J Neurotrauma 2006, 23(3–4):335–344.
6. Gonzalez CL, Kolb B: A comparison of different models of stroke on
behaviour and brain morphology. Eur J Neurosci 2003, 18(7):1950–1962.
7. Beattie MS: Inflammation and apoptosis: linked therapeutic targets in
spinal cord injury. Trends Mol Med 2004, 10(12):580–583.
8. Pekny M, Nilsson M: Astrocyte activation and reactive gliosis. Glia 2005,
50(4):427–434.
9. Sofroniew MV: Molecular dissection of reactive astrogliosis and glial scar
formation. Trends Neurosci 2009, 32(12):638–647.
10. Hall ED, Springer JE: Neuroprotection and acute spinal cord injury: a
reappraisal. NeuroRx 2004, 1(1):80–100.
11. Hall ED, Braughler JM: Central nervous system trauma and stroke. II.
Physiological and pharmacological evidence for involvement of oxygen
radicals and lipid peroxidation. Free Radic Biol Med 1989, 6(3):303–313.
12. Merrill JE, Murphy SP, Mitrovic B, Mackenzie-Graham A, Dopp JC, Ding M,
Griscavage J, Ignarro LJ, Lowenstein CJ: Inducible nitric oxide synthase
and nitric oxide production by oligodendrocytes. J Neurosci Res 1997,
48(4):372–384.
13. Grzybicki D, Gebhart GF, Murphy S: Expression of nitric oxide synthase
type II in the spinal cord under conditions producing thermal
hyperalgesia. J Chem Neuroanat 1996, 10(3–4):221–229.
14. Cai D, Qiu J, Cao Z, McAtee M, Bregman BS, Filbin MT: Neuronal cyclic AMP
controls the developmental loss in ability of axons to regenerate. J Neurosci
2001, 21(13):4731–4739.
15. Shen LF, Cheng H, Tsai MC, Kuo HS, Chak KF: PAL31 may play an
important role as inflammatory modulator in the repair process of the
spinal cord injury rat. J Neurochem 2009, 108(5):1187–1197.16. Oda M, Sun W, Hattori N, Tanaka S, Shiota K: PAL31 expression in rat
trophoblast giant cells. Biochem Biophys Res Commun 2001, 287(3):721–726.
17. Sun W, Kimura H, Hattori N, Tanaka S, Matsuyama S, Shiota K: Proliferation
related acidic leucine-rich protein PAL31 functions as a caspase-3 inhibitor.
Biochem Biophys Res Commun 2006, 342(3):817–823.
18. Zai LJ, Wrathall JR: Cell proliferation and replacement following contusive
spinal cord injury. Glia 2005, 50(3):247–257.
19. Cheng H, Cao Y, Olson L: Spinal cord repair in adult paraplegic rats:
partial restoration of hind limb function. Science 1996, 273(5274):510–513.
20. Lee MJ, Chen CJ, Huang WC, Huang MC, Chang WC, Kuo HS, Tsai MJ, Lin
YL, Cheng H: Regulation of chondroitin sulphate proteoglycan and
reactive gliosis after spinal cord transection: effects of peripheral nerve
graft and fibroblast growth factor 1. Neuropathol Appl Neurobiol 2011,
37(6):585–599.
21. Huang WC, Kuo WC, Cherng JH, Hsu SH, Chen PR, Huang SH, Huang MC,
Liu JC, Cheng H: Chondroitinase ABC promotes axonal re-growth and
behavior recovery in spinal cord injury. Biochem Biophys Res Commun
2006, 349(3):963–968.
22. Huang WC, Kuo WC, Hsu SH, Cheng CH, Liu JC, Cheng H: Gait analysis of
spinal cord injured rats after delivery of chondroitinase ABC and adult
olfactory mucosa progenitor cell transplantation. Neurosci Lett 2010,
472(2):79–84.
23. Tsai MJ, Weng CF, Shyue SK, Liou DY, Chen CH, Chiu CW, Yang TH, Pan HA,
Liao RI, Kuo HS, Huang MC, Huang WC, Hoffer BJ, Cheng H: Dual effect of
adenovirus-mediated transfer of BMP7 in mixed neuron-glial cultures:
neuroprotection and cellular differentiation. J Neurosci Res 2007,
85(13):2950–2959.
24. Tsai MJ, Chen YM, Weng CF, Liou DY, Yang HC, Chen CH, Liao RI, Kuo FS,
Chiu CW, Kuo HS, Huang MC, Lin YL, Lee MJ, Kuo WC, Huang WC, Cheng H:
Enhanced expression of glycine N-methyltransferase by adenovirus-
mediated gene transfer in CNS culture is neuroprotective. Ann N Y Acad
Sci 2010, 1199:194–203.
25. Tsai MJ, Tsai SK, Hu BR, Liou DY, Huang SL, Huang MC, Huang WC, Cheng H,
Huang SS: Recovery of neurological function of ischemic stroke by
application of conditioned medium of bone marrow mesenchymal stem
cells derived from normal and cerebral ischemia rats. J Biomed Sci 2014,
21:5.
26. Tsai MJ, Lee EH: Nitric oxide donors protect cultured rat astrocytes from
1-methyl-4-phenylpyridinium-induced toxicity. Free Radic Biol Med 1998,
24(5):705–713.
27. Tsai MJ, Lee EH: Differences in the disposition and toxicity of 1-methyl-4-
phenylpyridinium in cultured rat and mouse astrocytes. Glia 1994,
12(4):329–335.
28. Lin YL, Tsai MJ, Lo MJ, Chang SE, Shih YH, Lee MJ, Kuo HS, Kuo WC,
Huang WC, Cheng H, Huang MC: Evaluation of the antiangiogenic effect
of Kringle 1–5 in a rat glioma model. Neurosurgery 2012, 70(2):479–489.
discussion 489–90.
29. Tseng FW, Tsai MJ, Yu LY, Fu YS, Huang WC, Cheng H: Comparative effects
of bone marrow mesenchymal stem cells on lipopolysaccharide-induced
microglial activation. Oxid Med Cell Longev 2013, 2013:234179.
30. Tsai MJ, Weng CF, Yu NC, Liou DY, Kuo FS, Huang MC, Huang WC, Tam K,
Shyue SK, Cheng H: Enhanced prostacyclin synthesis by adenoviral gene
transfer reduced glial activation and ameliorated dopaminergic
dysfunction in hemiparkinsonian rats. Oxid Med Cell Longev 2013,
2013:649809.
31. Graeber MB, Streit WJ: Microglia: immune network in the CNS. Brain Pathol
1990, 1(1):2–5.
32. Slepko N, Levi G: Progressive activation of adult microglial cells in vitro.
Glia 1996, 16(3):241–246.
33. Donato R, Sorci G, Riuzzi F, Arcuri C, Bianchi R, Brozzi F, Tubaro C,
Giambanco I: S100B's double life: intracellular regulator and extracellular
signal. Biochim Biophys Acta 2009, 1793(6):1008–1022.
34. Nomura Y: NF-kappaB activation and IkappaB alpha dynamism involved
in iNOS and chemokine induction in astroglial cells. Life Sci 2001,
68(15):1695–1701.
35. Hwang J, Lee HJ, Lee WH, Suk K: NF-kappaB as a common signaling
pathway in ganglioside-induced autophagic cell death and activation of
astrocytes. J Neuroimmunol 2010, 226(1–2):66–72.
36. Barnabe-Heider F, Goritz C, Sabelstrom H, Takebayashi H, Pfrieger FW,
Meletis K, Frisen J: Origin of new glial cells in intact and injured adult
spinal cord. Cell Stem Cell 2010, 7(4):470–482.
Tseng et al. Journal of Biomedical Science 2014, 21:60 Page 12 of 12
http://www.jbiomedsci.com/content/21/1/6037. Faulkner JR, Herrmann JE, Woo MJ, Tansey KE, Doan NB, Sofroniew MV:
Reactive astrocytes protect tissue and preserve function after spinal cord
injury. J Neurosci 2004, 24(9):2143–2155.
38. Benda P, Lightbody J, Sato G, Levine L, Sweet W: Differentiated rat glial
cell strain in tissue culture. Science 1968, 161(3839):370–371.
39. Mutai H, Toyoshima Y, Sun W, Hattori N, Tanaka S, Shiota K: PAL31, a novel
nuclear protein, expressed in the developing brain. Biochem Biophys Res
Commun 2000, 274(2):427–433.
40. Sun W, Hattori N, Mutai H, Toyoshima Y, Kimura H, Tanaka S, Shiota K:
PAL31, a nuclear protein required for progression to the S phase.
Biochem Biophys Res Commun 2001, 280(4):1048–1054.
41. Liberatore GT, Jackson-Lewis V, Vukosavic S, Mandir AS, Vila M, McAuliffe
WG, Dawson VL, Dawson TM, Przedborski S: Inducible nitric oxide synthase
stimulates dopaminergic neurodegeneration in the MPTP model of
Parkinson disease. Nat Med 1999, 5(12):1403–1409.
42. Armato U, Chakravarthy B, Pacchiana R, Whitfield JF: Alzheimer's disease:
an update of the roles of receptors, astrocytes and primary cilia (review).
Int J Mol Med 2013, 31(1):3–10.
43. Colangelo AM, Alberghina L, Papa M: Astrogliosis as a therapeutic target
for neurodegenerative diseases. Neurosci Lett 2014, 565(17):59–64.
doi:10.1186/1423-0127-21-60
Cite this article as: Tseng et al.: Cytoprotective and anti-inflammatory
effects of PAL31 overexpression in glial cells. Journal of Biomedical
Science 2014 21:60.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
